Medtronic issues recall for MiniMed insulin pumps
Medtronic issues recall for MiniMed insulin pumps over battery issues
Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the issue has revealed that the devices may experience shortened battery life if they are dropped,
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages.
Medtronic shares dip after FDA tags insulin pump recall as Class I
Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.
Medtronic Recalls MiniMed 600/700 Series Insulin Pumps For Shortened Battery Life
Medtronic plc, an Irish healthcare technology company, is recalling its MiniMed 600 series or 700 series insulin pumps citing
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump.
Medtronic recalls select Minimed insulin delivery systems
Medtronic plc reported a voluntary recall of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.
Medtronic Recalls MiniMed Insulin Pumps Over Battery Issues -- Update
The Dublin-based medical-device maker said Friday that customers of its MiniMed 600 series or 700 series insulin pumps have reported shortened battery life in pumps that have been dropped or experienced some kind of physical impact that damaged internal components.
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Discover why Medtronic is a top Dividend Aristocrat with strong financial performance and potential for 12% annual returns ...
Becker's Spine Review5d
Medtronic in Q3: 4 notes
Medtronic leaned into its robotics and navigation strategy during the third quarter of 2024. Here are four things to know: 1. On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff ...
Yahoo Finance4d
Medtronic plc (NYSE:MDT) Shares Could Be 33% Below Their Intrinsic Value Estimate
The projected fair value for Medtronic is US$134 based on 2 Stage Free Cash Flow to Equity Medtronic's US$90.03 share price signals that it might be 33% undervalued The US$94.62 analyst price ...
Business Insider8d
Medtronic’s Buy Rating Justified by Growth in CST Sector and AiBLE’s Market Integration
Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00. Josh Jennings has given his Buy rating due to a ...